Clinical study of pembrolizumab combined with DEB-TACE in unresectable MSI-H/dMMR colorectal cancer liver metastasis
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务:
资源简介:
Interventions: Experimental group:Pembrolizumab + DEB-TACE Primary outcome(s): objective response rate Study Design: Single arm
创建时间:
2022-03-15




